Drug Profile
CLS 007
Alternative Names: CLS007Latest Information Update: 16 Apr 2019
Price :
$50
*
At a glance
- Originator Cutanea Life Sciences
- Class Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Acne
Most Recent Events
- 15 Mar 2019 Discontinued - Preregistration for Acne in USA (Topical)
- 08 Dec 2016 Preregistration for Acne in USA (Topical)